Register Study of the Neoadjuvanten Treatment by Patients With Rectumcarcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- Feasibilitystudy
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Radiation: 5x1,8Gy until 50,4 Gy Hyperthermia: 2x/week Chemotherapy: neoadjuvant= day 1-5 and day 29-33 5FU 1000mg/m2 adjuvant = 4 Cycles 5FU 500mg/m2 all 4 weeks
Radiation: 5x1,8Gy until 50,4 Gy Hyperthermia: 2x/week Chemotherapy: neoadjuvant= day 1-5 and day 29-33 5FU 1000mg/m2 adjuvant = 4 Cycles 5FU 500mg/m2 all 4 weeks
Tracking Information
- NCT #
- NCT03428867
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Daniel Zips, Prof.Dr. University Hospital Tuebingen
Get Well Soon